Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
2.
Cancer ; 119 Suppl 11: 2087-8, 2013 Jun 01.
Article in English | MEDLINE | ID: mdl-23695920
4.
Health Educ Behav ; 38(2): 111-5, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21595092

ABSTRACT

This article examines the current state of the global fight against cancer and of noncommunicable disease in general, the progress to date against cancer, and postulates that there has never been a more challenging­nor more ideal­time to succeed in making significant headway against the disease worldwide. Based on progress made particularly in the past two decades, and with proven interventions and scientific knowledge, it is possible to bring cancer as a major health problem worldwide under control in this century.The article also discusses what the American Cancer Society, the nation's largest voluntary health organization dedicated to saving lives from cancer, is doing to lead a global movement in support of achieving this goal.


Subject(s)
American Cancer Society , Global Health , Neoplasms/prevention & control , Public Health/trends , Health Behavior , Humans , Neoplasms/economics , Neoplasms/therapy , Survival Rate/trends , United States
6.
Lancet ; 376(9747): 1186-93, 2010 Oct 02.
Article in English | MEDLINE | ID: mdl-20709386

ABSTRACT

Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.


Subject(s)
Antineoplastic Agents/economics , Antineoplastic Agents/therapeutic use , Developing Countries/economics , Health Policy , Health Services Accessibility/economics , Neoplasms , Poverty , Colombia , Early Detection of Cancer , Global Health , Haiti , Health Services Accessibility/standards , Health Services Accessibility/trends , Health Services Needs and Demand , Hepatitis B Vaccines/administration & dosage , Humans , Incidence , Income , Insurance Coverage , Insurance, Health , Jordan , Malawi , Mass Screening , Mexico , Neoplasms/diagnosis , Neoplasms/economics , Neoplasms/epidemiology , Neoplasms/mortality , Neoplasms/prevention & control , Neoplasms/therapy , Papillomavirus Vaccines/administration & dosage , Public Health , Risk Factors , Rwanda , Smoking Cessation , Socioeconomic Factors
7.
CA Cancer J Clin ; 60(1): 50-61, 2010.
Article in English | MEDLINE | ID: mdl-20097837

ABSTRACT

The globalization of tobacco began more than 500 years ago, but the public health response to the death, disease, and economic disruption that it has caused is fewer than 50 years old. In this report, the authors briefly trace the history of tobacco use and commerce as it moved from the Americas in the late 15th century and then eastward. They then discuss the wide range of issues that must be addressed, and the equally wide range of expertise that is needed if the global health community is to be successful in reducing, and eventually eliminating, the rising tide of tobacco use, particularly in the low- and middle-income nations that are the target of the multinational tobacco industry.


Subject(s)
Health Education/organization & administration , Marketing/organization & administration , Marketing/trends , Smoking Prevention , Smoking/epidemiology , Tobacco Industry/trends , Tobacco Use Disorder/prevention & control , Adolescent , Advertising/trends , Child , Disease Outbreaks/prevention & control , Disease Outbreaks/statistics & numerical data , Forecasting , Global Health , Health Education/methods , Health Education/trends , Humans , Internationality , Marketing/methods , Nicotiana , Tobacco Industry/legislation & jurisprudence , Tobacco Smoke Pollution/prevention & control , Young Adult
10.
Ethn Dis ; 17(2 Suppl 3): S3-8-S3-9, 2007.
Article in English | MEDLINE | ID: mdl-17985439

ABSTRACT

Cancer incidence is on the rise in many regions of the world, including the Middle East, where incidence rates for both men and women are increasing. Like many regions of the world, increased tobacco use, combined with other factors, is driving cancer incidence in the Middle East. Tobacco, the only consumer product proven to kill more than half of its regular users, will be responsible for 4.9 million deaths worldwide this year alone. That burden is fairly evenly shared by industrialized and developing nations today but, if current trends continue, the cancer burden in the developing world will more than triple in the next 25 years, resulting in a global total of 10 million deaths worldwide each year. Seven million of these deaths will occur in the developing world, in nations least prepared to deal with the financial, social, and political consequences of this global public health tragedy. In the Arab world, lung cancer is already occurring with increasing frequency, particularly among men.


Subject(s)
Arabs , Neoplasms/etiology , Smoking/adverse effects , Female , Humans , Male , Middle East/epidemiology , Middle East/ethnology , Neoplasms/epidemiology , Smoking/ethnology , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...